Skip to main content


Prostate Cancer

Featured

Conference Coverage
In a large representative sample of US patients with metastatic castration-sensitive prostate cancer, less than one-third of patients received advanced therapies by 2018, and this…
Conference Coverage
More than half of patients with metastatic castration-sensitive prostate cancer did not receive first-line treatment…
News
A recent study comparing radiotherapy methods for prostate cancer suggests that physician-reported toxicities may be…
Quiz
True or False: Moving toward hypofractionation for treating localized, intermediate-risk prostate cancer, is the most…
Videos
Lucio Gordan, MD, discusses results from a study analyzing the impact of late dosing of two leuprolide acetate…
Back to Top